In a regulatory filing yesterday, Moderna disclosed that its director Noubar Afeyan sold 15K shares of common stock on July 19th in a total transaction size of $1.88M.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on MRNA:
- Moderna president Hoge sells 15,000 common shares
- Buy/Sell: Wall Street’s top 10 stock calls this week
- Moderna initiated with a Reduce at HSBC
- Moderna (NYSE:MRNA) Chooses to Cater to Chinese Consumers
- MRNA Stock Jumps as It Progresses with RSV Vaccine Application
Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.
Report an Issue